Mark Brosius - 27 Feb 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
SVP & Chief Mfg and Supply Cha
Signature
By: Stephanie Lim-Ignacio For: Brosius, Mark
Issuer symbol
ISRG
Transactions as of
27 Feb 2025
Net transactions value
-$1,753,739
Form type
4
Filing time
03 Mar 2025, 19:32:38 UTC
Previous filing
27 Feb 2025
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Award $0 +4,385 +231% $0.000000 6,281 27 Feb 2025 Direct F1
transaction ISRG Common Stock Options Exercise $0 +877 +14% $0.000000 7,158 28 Feb 2025 Direct F2
transaction ISRG Common Stock Tax liability $245,240 -435 -6.1% $563.77 6,723 28 Feb 2025 Direct F2
transaction ISRG Common Stock Tax liability $1,226,200 -2,175 -32% $563.77 4,548 28 Feb 2025 Direct F3
transaction ISRG Common Stock Sale $282,300 -492 -11% $573.78 4,056 03 Mar 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Restricted Stock Units - 2-28-2022 Options Exercise $0 -877 -50% $0.000000 877 28 Feb 2025 Common Stock 877 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction represents the certification of the performance goals under performance stock units ("PSUs").
F2 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F3 This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.
F4 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 13, 2025.
F5 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.